Equities Analysts Set Expectations for Amdocs Q1 Earnings

Amdocs Limited (NASDAQ:DOX) – Investment analysts at Zacks Research raised their Q1 2028 EPS estimates for Amdocs in a report issued on Tuesday, February 24th. Zacks Research analyst Team now anticipates that the technology company will post earnings of $1.82 per share for the quarter, up from their previous forecast of $1.78. The consensus estimate for Amdocs’ current full-year earnings is $6.21 per share. Zacks Research also issued estimates for Amdocs’ FY2028 earnings at $7.55 EPS.

Amdocs (NASDAQ:DOX) last issued its quarterly earnings data on Tuesday, February 3rd. The technology company reported $1.81 EPS for the quarter, topping the consensus estimate of $1.75 by $0.06. Amdocs had a net margin of 12.47% and a return on equity of 20.19%. The business had revenue of $1.16 billion during the quarter, compared to analyst estimates of $1.15 billion. During the same period in the prior year, the business earned $1.66 EPS. The company’s revenue for the quarter was up 4.1% on a year-over-year basis. Amdocs has set its Q2 2026 guidance at 1.730-1.790 EPS and its FY 2026 guidance at 7.270-7.550 EPS.

A number of other analysts also recently weighed in on DOX. Barclays reduced their target price on shares of Amdocs from $111.00 to $92.00 and set an “overweight” rating on the stock in a research report on Wednesday, February 4th. Wall Street Zen raised Amdocs from a “hold” rating to a “buy” rating in a research note on Saturday, February 7th. Wolfe Research reiterated a “peer perform” rating on shares of Amdocs in a research note on Thursday, November 13th. Weiss Ratings reiterated a “hold (c)” rating on shares of Amdocs in a report on Tuesday, January 27th. Finally, Bank of America decreased their target price on Amdocs from $100.00 to $97.00 and set a “buy” rating for the company in a research report on Wednesday, November 12th. Three analysts have rated the stock with a Buy rating and two have given a Hold rating to the company. According to data from MarketBeat.com, Amdocs currently has a consensus rating of “Moderate Buy” and a consensus price target of $92.33.

Amdocs Price Performance

DOX opened at $69.86 on Thursday. The company has a current ratio of 1.06, a quick ratio of 1.06 and a debt-to-equity ratio of 0.23. The company has a market cap of $7.54 billion, a price-to-earnings ratio of 13.51, a price-to-earnings-growth ratio of 1.18 and a beta of 0.40. The stock has a fifty day simple moving average of $77.84 and a two-hundred day simple moving average of $80.68. Amdocs has a 12-month low of $65.74 and a 12-month high of $95.41.

Amdocs Increases Dividend

The firm also recently disclosed a quarterly dividend, which will be paid on Friday, April 24th. Stockholders of record on Tuesday, March 31st will be given a dividend of $0.569 per share. This represents a $2.28 dividend on an annualized basis and a dividend yield of 3.3%. The ex-dividend date of this dividend is Tuesday, March 31st. This is a positive change from Amdocs’s previous quarterly dividend of $0.53. Amdocs’s payout ratio is presently 40.81%.

Institutional Inflows and Outflows

Large investors have recently modified their holdings of the company. MidFirst Bank bought a new stake in Amdocs during the fourth quarter valued at about $54,000. Pacer Advisors Inc. purchased a new position in Amdocs during the fourth quarter valued at $25,506,000. EP Wealth Advisors LLC bought a new stake in Amdocs in the 4th quarter valued at $631,000. Mackenzie Financial Corp lifted its stake in Amdocs by 218.0% in the 4th quarter. Mackenzie Financial Corp now owns 118,898 shares of the technology company’s stock worth $9,644,000 after purchasing an additional 81,504 shares in the last quarter. Finally, NewEdge Advisors LLC boosted its holdings in shares of Amdocs by 8.6% during the 4th quarter. NewEdge Advisors LLC now owns 11,276 shares of the technology company’s stock valued at $908,000 after purchasing an additional 897 shares during the last quarter. Hedge funds and other institutional investors own 92.02% of the company’s stock.

Amdocs Company Profile

Amdocs (NASDAQ: DOX) is a global software and services provider specializing in solutions for communications, media and entertainment companies. The company designs, develops and integrates revenue management, customer experience and digital services platforms that enable service providers to launch and monetize new offerings, streamline operations and enhance subscriber engagement. Amdocs’ product suite encompasses billing and order management, customer relationship management, digital commerce and network function virtualization, supported by professional services for implementation, integration and managed operations.

Founded in 1982 and structured as a separate public company in 1998, Amdocs has its corporate headquarters in Chesterfield, Missouri, and maintains major development centers in Ra’anana, Israel.